These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 19177806

  • 1. [Thrombolysis by intravenous tissue plasminogen activator (t-PA)--current status and future direction].
    Tanahashi N.
    Brain Nerve; 2009 Jan; 61(1):41-52. PubMed ID: 19177806
    [Abstract] [Full Text] [Related]

  • 2. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T, Minematsu K.
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [Abstract] [Full Text] [Related]

  • 3. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
    Kono S, Deguchi K, Morimoto N, Kurata T, Yamashita T, Ikeda Y, Narai H, Manabe Y, Takao Y, Kawada S, Kashihara K, Takehisa Y, Inoue S, Kiriyama H, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
    [Abstract] [Full Text] [Related]

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D, Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology, Technology Assessment Committee of the Society of Interventional Radiology.
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [Abstract] [Full Text] [Related]

  • 5. Effects of edaravone, a free radical scavenger, on circulating levels of MMP-9 and hemorrhagic transformation in patients with intravenous thrombolysis using low-dose alteplase.
    Tsuruoka A, Atsumi C, Mizukami H, Imai T, Hagiwara Y, Hasegawa Y.
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(10):2894-2899. PubMed ID: 25282183
    [Abstract] [Full Text] [Related]

  • 6. Simultaneous administration of recombinant tissue plasminogen activator and edaravone in acute cerebral ischemic stroke patients.
    Takenaka K, Kato M, Yamauti K, Hayashi K.
    J Stroke Cerebrovasc Dis; 2014 Aug; 23(10):2748-2752. PubMed ID: 25307430
    [Abstract] [Full Text] [Related]

  • 7. Recanalization of middle cerebral artery and intracranial aneurysm in the same ischemic territory with intravenous administration of recombinant tissue plasminogen activator: case report.
    Matsuzaki T, Yoshino A, Sakatani K, Katayama Y.
    J Stroke Cerebrovasc Dis; 2011 Aug; 20(3):269-72. PubMed ID: 20630773
    [Abstract] [Full Text] [Related]

  • 8. Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.
    Kimura K, Iguchi Y, Shibazaki K, Kobayashi K, Uemura J, Aoki J, Yamashita S, Terasawa Y, Matsumoto N.
    J Neurol Sci; 2008 Jul 15; 270(1-2):48-52. PubMed ID: 18304581
    [Abstract] [Full Text] [Related]

  • 9. The free-radical scavenger edaravone accelerates thrombolysis with alteplase in an experimental thrombosis model.
    Yamashita T, Sato T, Sakamoto K, Ishii H, Yamamoto J.
    Thromb Res; 2015 Jun 15; 135(6):1209-13. PubMed ID: 25908261
    [Abstract] [Full Text] [Related]

  • 10. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.
    J Stroke Cerebrovasc Dis; 2013 Apr 15; 22(3):190-6. PubMed ID: 21968092
    [Abstract] [Full Text] [Related]

  • 11. Comparison of MRI-based thrombolysis for patients with middle cerebral artery occlusion<or=3 h and 3-6 h.
    Li YH, Li MH, Zhao ZG, Bai QK.
    Neurol India; 2009 Apr 15; 57(4):426-33. PubMed ID: 19770543
    [Abstract] [Full Text] [Related]

  • 12. Three cases of middle cerebral artery occlusion emergently revascularized with a balloon-expandable coronary bare stent after intravenous tissue plasminogen activator.
    Fukuoka T, Dembo T, Nagoya H, Deguchi I, Maruyama H, Kanazawa R, Kohyama S, Yamane F, Ishihara S, Tanahashi N.
    J Stroke Cerebrovasc Dis; 2012 Nov 15; 21(8):883-9. PubMed ID: 21767964
    [Abstract] [Full Text] [Related]

  • 13. Outcome of Acute Ischemic Stroke after the Treatment with Edaravone and 0.6 Mg/Kg Alteplase in Japanese Patients with Diabetes.
    Tanahashi N, Yamaguchi T, Awano H, Matsuda H.
    J Stroke Cerebrovasc Dis; 2018 May 15; 27(5):1302-1310. PubMed ID: 29373227
    [Abstract] [Full Text] [Related]

  • 14. Administration of edaravone, a free radical scavenger, during t-PA infusion can enhance early recanalization in acute stroke patients--a preliminary study.
    Kimura K, Aoki J, Sakamoto Y, Kobayashi K, Sakai K, Inoue T, Iguchi Y, Shibazaki K.
    J Neurol Sci; 2012 Feb 15; 313(1-2):132-6. PubMed ID: 21967833
    [Abstract] [Full Text] [Related]

  • 15. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS).
    Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Höxter G, Mahagne MH.
    JAMA; 1995 Oct 04; 274(13):1017-25. PubMed ID: 7563451
    [Abstract] [Full Text] [Related]

  • 16. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
    Clark WM, Wissman S, Albers GW, Jhamandas JH, Madden KP, Hamilton S.
    JAMA; 1999 Dec 01; 282(21):2019-26. PubMed ID: 10591384
    [Abstract] [Full Text] [Related]

  • 17. European Cooperative Acute Stroke Study-4: Extending the time for thrombolysis in emergency neurological deficits ECASS-4: ExTEND.
    Amiri H, Bluhmki E, Bendszus M, Eschenfelder CC, Donnan GA, Leys D, Molina C, Ringleb PA, Schellinger PD, Schwab S, Toni D, Wahlgren N, Hacke W.
    Int J Stroke; 2016 Feb 01; 11(2):260-7. PubMed ID: 26783318
    [Abstract] [Full Text] [Related]

  • 18. Stroke in a child safely treated with intravenous tissue plasminogen activator and edaravone, a free radical scavenger.
    Baba H, Sugimori H, Nanishi E, Nagata H, Lee S, Kuwashiro T, Hashizume M.
    J Stroke Cerebrovasc Dis; 2012 Nov 01; 21(8):903.e5-8. PubMed ID: 21421331
    [Abstract] [Full Text] [Related]

  • 19. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I, Raman R, Ernstrom K, Meyer BC, Hemmen TM.
    J Stroke Cerebrovasc Dis; 2014 Nov 01; 23(5):1046-50. PubMed ID: 24103663
    [Abstract] [Full Text] [Related]

  • 20. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.
    Koga M, Toyoda K, Kimura K, Yamamoto H, Sasaki M, Hamasaki T, Kitazono T, Aoki J, Seki K, Homma K, Sato S, Minematsu K, THAWS investigators.
    Int J Stroke; 2014 Dec 01; 9(8):1117-24. PubMed ID: 25088843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.